Central Application of Aliskiren, a Renin Inhibitor, Improves Outcome After Experimental Stroke Independent of Its Blood Pressure Lowering Effect.
- DOI
- 10.3389/fneur.2019.00942
- Published
- 2019
- Container
- Frontiers in neurology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fneur.2019.00942,
title = {Central Application of Aliskiren, a Renin Inhibitor, Improves Outcome After Experimental Stroke Independent of Its Blood Pressure Lowering Effect.},
author = {Panahpour H and Terpolilli NA and Schaffert D and Culmsee C and Plesnila N},
year = {2019},
journal = {Frontiers in neurology},
doi = {10.3389/fneur.2019.00942},
url = {https://doi.org/10.3389/fneur.2019.00942}
}RIS
TY - JOUR TI - Central Application of Aliskiren, a Renin Inhibitor, Improves Outcome After Experimental Stroke Independent of Its Blood Pressure Lowering Effect. AU - Panahpour H AU - Terpolilli NA AU - Schaffert D AU - Culmsee C AU - Plesnila N PY - 2019 JO - Frontiers in neurology DO - 10.3389/fneur.2019.00942 UR - https://doi.org/10.3389/fneur.2019.00942 ER -
APA
H, P., NA, T., D, S., C, C., & N, P. (2019). Central Application of Aliskiren, a Renin Inhibitor, Improves Outcome After Experimental Stroke Independent of Its Blood Pressure Lowering Effect.. Frontiers in neurology. https://doi.org/10.3389/fneur.2019.00942
Source records
- pubmed · retrieved 2026-09-25T08:35:35.007Z
- europe-pmc · retrieved 2026-09-25T08:35:35.018Z
- doaj · retrieved 2026-09-25T08:35:35.022Z